INTERVIEW

ACCELERATING ACCESS: THE FUTURE OF INJECTABLES IS PREFILLED AND PLASTIC – AN INTERVIEW WITH APIJECT’S BO KOWALCZYK & JON ELLENTHAL

ACCELERATING ACCESS: THE FUTURE OF INJECTABLES IS PREFILLED AND PLASTIC – AN INTERVIEW WITH APIJECT’S BO KOWALCZYK & JON ELLENTHAL

Bo Kowalczyk and Jon Ellenthal discuss the need for greater fill-finish capacity in the pharmaceutical industry highlighted by the covid-19 pandemic, and how ApiJect’s Blow-Fill-Seal prefilled injector platform aims to meet this need.

Interview with Julien Martins & David Philbrick

Paragon Medical

Interview with Julien Martins & David Philbrick

Julien Martins and David Philbrick talk exclusively with ONdrugDelivery's Guy Furness. They discuss a wide range of topics, including the services Paragon Medical provides the drug delivery industry, its wider business operations, the company’s expanded facilities in the US and Europe, and its new Advanced Surgical Innovation Center.

CONNECTING PHARMA: INSIGHTS FROM AUTOMOTIVE INDUSTRY EXPERIENCE

EdgeOne Medical

CONNECTING PHARMA: INSIGHTS FROM AUTOMOTIVE INDUSTRY EXPERIENCE

Jim McGough talks with Guy Furness about the current state and future of connectivity in drug delivery and pharma more broadly. In an enlightening discussion, Mr McGough shares insights from his time pioneering connectivity in the automotive industry at Volkswagen Group and how those lessons might apply to pharma, as well as considering what might be holding the industry back from going full steam ahead on connectivity and how that might change over the next decade.

Interview with Arnaud Guillet & Fanny Sellier

Interview with Arnaud Guillet & Fanny Sellier

Arnaud Guillet and Fanny Sellier talk with Guy Furness about how Biocorp has become a key player in the field of connected drug delivery, discuss the current landscape for connectivity in drug delivery and update us on its two major parenteral products – Mallya and Injay – as well as looking forward to the launch of the company’s next generation of connected drug delivery solutions.

WHY SUSTAINABLE PACKAGING MATTERS IN PHARMA’S CIRCULAR APPROACH – APTAR PHARMA’S FUTURITY PLATFORM LEADS THE WAY

WHY SUSTAINABLE PACKAGING MATTERS IN PHARMA’S CIRCULAR APPROACH – APTAR PHARMA’S FUTURITY PLATFORM LEADS THE WAY

Julien Storz discusses the importance of sustainable packaging in the pharma industry and introduces the company’s Futurity platform and its role in product circularity.

DE-RISKING COMBINATION PRODUCT REGISTRATION FOR SEMI-SOLIDS WITH APTAR PHARMA’S AIRLESS<sup>+</sup> SYSTEM – AN INTERVIEW WITH STEFAN HELLBARDT

Dr Stefan Hellbardt

DE-RISKING COMBINATION PRODUCT REGISTRATION FOR SEMI-SOLIDS WITH APTAR PHARMA’S AIRLESS⁺ SYSTEM – AN INTERVIEW WITH STEFAN HELLBARDT

Stefan Hellbardt discusses the increasing demand for airless systems in the dermal drug delivery market, the advantages of these systems and Aptar Pharma’s own offering in this space, including its Airless+ packaging system and Extended Support services.

Interview: Kymanox Executive Advisors Mathias Romacker, Fran DeGrazio & Paul Jansen

Interview: Kymanox Executive Advisors Mathias Romacker, Fran DeGrazio & Paul Jansen

Mathias Romacker, Fran DeGrazio and Paul Jansen sit down with Guy Furness, to discuss what it is that has driven Kymanox’s rapid rise in the drug delivery space and what makes the consulting company’s model so successful, as well as to share their expertise on a variety of topics in an illuminating discussion, including connectivity, how large and small drug developers engage with consultancies, 5 mL autoinjectors and the interface between drug primary packaging and delivery devices.

Interview: Gabriel Zenker, Aptar Pharma

Interview: Gabriel Zenker, Aptar Pharma

Gabriel Zenker talks with ONdrugDelivery about Aptar Pharma’s ambitions for the parenterals sector. Mr Zenker explains how Aptar, already a major player in the pulmonary, nasal, ophthalmic and dermal markets, is undertaking a major expansion of its facilities, boosting the company’s capacity, capabilities and technologies, to provide its extensive service and product offering to the exciting injectables space.

Pharmapack Expert Panel on Patient-Centric Digital Health: Interview with Ben Cox, Team Consulting

Team Consulting

Pharmapack Expert Panel on Patient-Centric Digital Health: Interview with Ben Cox, Team Consulting

With Pharmapack returning to its traditional February timing in 2023, Team Consulting will be chairing a Day 1 expert panel discussion on patient-centric digital health solutions. Interviewed here, Ben Cox provides insight into trends the panel will discuss, lays out the current status of the industry with respect to digital health and considers what to look forward to at Pharmapack this year.

Connected Drug Delivery – Is the Near-Term Opportunity in Clinical Development? – an Interview with Oliver Eden

Jabil Healthcare

Connected Drug Delivery – Is the Near-Term Opportunity in Clinical Development? – an Interview with Oliver Eden

Oliver Eden of Jabil Healthcare looks at the factors influencing the return on investment metrics in clinical development and introduces Jabil’s autoinjector platform Qfinity™ and its connected version, Qfinity+™.

Interview with Biocorp’s Arnaud Guillet

Interview with Biocorp’s Arnaud Guillet

In this exclusive interview, Arnaud Guillet of Biocorp talks with ONdrugDelivery about connectivity in the injectables space, sharing some of the insights Biocorp has gained from its decade of experience in developing connected drug delivery devices.

INTERVIEW: RENAN JOEL, CONNECT IN PHARMA CONFERENCE

INTERVIEW: RENAN JOEL, CONNECT IN PHARMA CONFERENCE

Renan Joel, Easyfairs' Divisional Director Packaging – UK, France, Italy & Switzerland, talks with ONdrugDelivery about the upcoming inaugural Connect in Pharma conference in Geneva.

INTERVIEW: Piyush Agarwal, Tjoapack

INTERVIEW: Piyush Agarwal, Tjoapack

Piyush Agarwal talks with ONdrugDelivery about the current state of the injectable pharmaceuticals market and how working with a specialist contract packaging organisation can help pharma companies navigate their product through this rapidly evolving sector and deliver their product to market on time.

ROUNDTABLE: TRENDS AND INNOVATIONS IN ORAL DRUG DELIVERY

ROUNDTABLE: TRENDS AND INNOVATIONS IN ORAL DRUG DELIVERY

Michael Morgen of Lonza Bend, Torkel Gren of Recipharm, and Yogesh Sadhale of Metrics Contract Services, discuss the current trends and innovations influencing oral drug delivery development and what their respective companies can offer to pharma in this space.

INTERVIEW: STEVEN KAUFMAN, STEVANATO GROUP, & MICHAEL EARL, OWEN MUMFORD

Stevanato Group

INTERVIEW: STEVEN KAUFMAN, STEVANATO GROUP, & MICHAEL EARL, OWEN MUMFORD

In this exclusive interview, Steven Kaufman of Stevanato Group, and Michael Earl of Owen Mumford, talked with us about their companies' recent major agreement for the manufacturing and provision of prefillable syringes for the advanced two-step, single-use autoinjector, Aidaptus^®.

INTERVIEW: AURELIO ARIAS, IQVIA

INTERVIEW: AURELIO ARIAS, IQVIA

Aurelio Arias of IQVIA discusses trends in the drug delivery industry, including how device and packaging manufacturers are increasingly aligning as strategic partners to speed innovation and reduce reliance on pharma investment.

INTERVIEW: JON LENN & JON VOLMER, MEDPHARM

INTERVIEW: JON LENN & JON VOLMER, MEDPHARM

Jon Lenn and Jon Volmer talked with Guy Furness about the importance of nasal modelling, focusing on MedPharm’s own nasal cavity modelling technology, MedCast, its unique characteristics and benefits and the value it brings to the company’s offering for nasally delivered products.

INTERVIEW: Natalia Servol, Unither Pharmaceuticals

Unither Pharmaceuticals

INTERVIEW: Natalia Servol, Unither Pharmaceuticals

In this interview, Natalia Servol, Head of Unither Pharmaceuticals’ Ophthalmic Business, speaks about the company's equipment for compounding and fill-finish of preservative-free products into multidose bottles, part of Unither’s unique and innovative preservative-free multidose offering for partners.

Interview: Arnaud Guillet, Biocorp

Interview: Arnaud Guillet, Biocorp

In this exclusive interview with ONdrugDelivery, Arnaud Guillet discusses Mallya, Biocorp’s connected clip-on for pen injectors, including Mallya’s successful launch in multiple countries this year, the factors that have played into the device’s success, and the future for Mallya, Biocorp and connectivity in the drug delivery industry.

ROUNDTABLE: CAPSULE-BASED DRY POWDER INHALERS

Frédérique Bordes-Picard

ROUNDTABLE: CAPSULE-BASED DRY POWDER INHALERS

Frédérique Bordes-Picard of Lonza, Marco Franza of Berry, Mirjam Kobler of Meggle, and Marco Laackmann of Harro Höfliger, discuss the accelerating development potential of capsule-based dry powder inhalers (DPIs) and the potential of these effective and efficient drug delivery devices in the modern drug delivery market.

ROUNDTABLE: ALLIANCE TO ZERO

Sebastian Gerner

Alliance to Zero

ROUNDTABLE: ALLIANCE TO ZERO

Sebastian Gerner, Robert O’Beirn and Sabrina Gérard talk with ONdrugDelivery about the Alliance to Zero, an association for pharma and biotech supply chain companies that aims to facilitate the transition of the pharma sector to compliance with net-zero emissions.

INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT

Mathias Romacker

INTERVIEW WITH MATHIAS ROMACKER, EX-PFIZER, INJECTION DEVICES STRATEGY CONSULTANT

In this exclusive interview, Mathias Romacker discusses a broad range of topics, from his professional expertise and history seeing the parenteral sector evolve first-hand, to his personal experience as a Crohn’s disease patient making use of the very devices he’s seen grow and develop.

INTERVIEW WITH STEPHEN M PERRY AND NICHOLAS CICCARELLI

INTERVIEW WITH STEPHEN M PERRY AND NICHOLAS CICCARELLI

Stephen Perry and Nicholas Ciccarelli discuss the August 2021 acquisition of Neuma by Kymanox, highlighting how the acquisition has positioned Kymanox to lead the development of particularly complex drug delivery systems and cutting-edge medical device technologies, providing additional services to progress combination products to market.

INTERVIEW WITH BENJAMIN DIETIKER, WEIDMANN MEDICAL TECHNOLOGY

Benjamin Dietiker

INTERVIEW WITH BENJAMIN DIETIKER, WEIDMANN MEDICAL TECHNOLOGY

Benjamin Dietiker, Weidmann Medical Technology, talks with ONdrugDelivery about how the company has successfully implemented a growth strategy by focusing on key areas, plans for expansion, the effect of covid-19 on the business, and how the company differentiates itself from larger competitors by focusing on quality and service.

Prev
1
2
3
4
5
Next

Top